Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Lipidology|May 29, 2010
Apolipoprotein B synthesis inhibition: results from clinical trialsMaartje E Visser, John J P Kastelein, Erik S G Stroes
Current Cardiology Reports|October 28, 2008
LDL-C-lowering therapy: current and future therapeutic targetsMaartje E Visser, Lily Jakulj, John J P Kastelein, et al.
European Heart Journal|May 29, 2012
Antisense oligonucleotides for the treatment of dyslipidaemiaMaartje E Visser, Joseph L Witztum, Erik S G Stroes, et al.
Journal of Lipid Research|December 17, 2009
Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemiaMaartje E Visser, Fatima Akdim, Diane L Tribble, et al.
Atherosclerosis|February 2, 2010
The metabolism of triglyceride-rich lipoproteins revisited: new players, new insightGeesje M Dallinga-Thie, Remco Franssen, Hans L Mooij, et al.
International Journal of Cardiology|April 28, 2009
Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyJamal S Rana, Maartje E Visser, Benoit J Arsenault, et al.
The American Journal of Cardiology|May 11, 2010
Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemiaFatima Akdim, Maartje E Visser, Diane L Tribble, et al.
Nature Genetics|July 27, 2010
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemiaChristopher T Johansen, Jian Wang, Matthew B Lanktree, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 21, 2011
An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemiaChristopher T Johansen, Jian Wang, Matthew B Lanktree, et al.
Pageof 1